Literature DB >> 17898159

Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test.

François Coutlée1, Danielle Rouleau, Georges Ghattas, Catherine Hankins, Sylvie Vézina, Pierre Coté, John Macleod, Alexandra de Pokomandy, Deborah Money, Sharon Walmsley, Hélène Voyer, Paul Brassard, Eduardo Franco.   

Abstract

A novel real-time PCR assay for detection of human papillomavirus type 52 (HPV-52) DNA (RT-52) was evaluated on 265 anogenital samples. RT-52 had a sensitivity of 98.4% and a specificity of 100% compared to conventional HPV-52 typing assays, including hybridization of PGMY products with an HPV-52-specific probe and PCR sequencing of HPV-52 E6.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17898159      PMCID： PMC2168527          DOI： 10.1128/JCM.01145-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 2.  Clinical utility of HPV genotyping.

Authors:  Chris J Meijer; Peter J Snijders; Philip E Castle
Journal:  Gynecol Oncol       Date:  2006-08-24       Impact factor: 5.482

Review 3.  Persistent human papillomavirus infection and cervical neoplasia.

Authors:  Alex Ferenczy; Eduardo Franco
Journal:  Lancet Oncol       Date:  2002-01       Impact factor: 41.316

4.  Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. The Canadian Women's HIV study group.

Authors:  F Coutlée; P Gravitt; H Richardson; C Hankins; E Franco; N Lapointe; H Voyer
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 5.  Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer.

Authors:  Gary M Clifford; Rashida K Rana; Silvia Franceschi; Jennifer S Smith; Gerald Gough; Jeanne M Pimenta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-05       Impact factor: 4.254

6.  Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.

Authors:  Rolando Herrero; Philip E Castle; Mark Schiffman; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Sabrina Chen; Ana C Rodriguez; Robert D Burk
Journal:  J Infect Dis       Date:  2005-05-02       Impact factor: 5.226

7.  Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.

Authors:  C Hankins; F Coutlée; N Lapointe; P Simard; T Tran; J Samson; L Hum
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

Review 8.  Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.

Authors:  Thomas C Wright; Mark Schiffman; Diane Solomon; J Thomas Cox; Francisco Garcia; Sue Goldie; Kenneth Hatch; Kenneth L Noller; Nancy Roach; Carolyn Runowicz; Debbie Saslow
Journal:  Obstet Gynecol       Date:  2004-02       Impact factor: 7.661

9.  Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women.

Authors:  Joséphine Aho; Catherine Hankins; Cécile Tremblay; Franz Lang; Pierre Forest; Karina Pourreaux; Fabrice Rouah; François Coutlée
Journal:  J Infect Dis       Date:  2003-10-23       Impact factor: 5.226

10.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis.

Authors:  G M Clifford; J S Smith; M Plummer; N Muñoz; S Franceschi
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640
View more
  22 in total

1.  Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types.

Authors:  Vanessa Zubach; Gerry Smart; Samuel Ratnam; Alberto Severini
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

2.  Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix.

Authors:  Simon Grandjean Lapierre; Philippe Sauthier; Marie-Hélène Mayrand; Simon Dufresne; Patrick Petignat; Diane Provencher; Pierre Drouin; Philippe Gauthier; Marie-Josée Dupuis; Bertrand Michon; Stéphan Ouellet; Rachid Hadjeres; Alex Ferenczy; Eduardo L Franco; François Coutlée
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

3.  The 2010 global proficiency study of human papillomavirus genotyping in vaccinology.

Authors:  Carina Eklund; Ola Forslund; Keng-Ling Wallin; Tiequn Zhou; Joakim Dillner
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

4.  Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes.

Authors:  C Estrade; P-A Menoud; D Nardelli-Haefliger; R Sahli
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

5.  Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.

Authors:  Samuel Ratnam; Francois Coutlee; Dan Fontaine; James Bentley; Nicholas Escott; Prafull Ghatage; Veeresh Gadag; Glen Holloway; Elias Bartellas; Nick Kum; Christopher Giede; Adrian Lear
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

6.  Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens.

Authors:  Joseph E Tota; Agnihotram V Ramanakumar; Luisa L Villa; Harriet Richardson; Ann N Burchell; Anita Koushik; Marie-Hélène Mayrand; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-02       Impact factor: 4.254

7.  Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women.

Authors:  Tasneem Shikary; David I Bernstein; Yan Jin; Gregory D Zimet; Susan L Rosenthal; Jessica A Kahn
Journal:  J Clin Virol       Date:  2009-08-08       Impact factor: 3.168

8.  Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.

Authors:  Philip E Castle; Patti E Gravitt; Diane Solomon; Cosette M Wheeler; Mark Schiffman
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

9.  Human Papillomavirus (HPV) Type Distribution in Females with Abnormal Cervical Cytology. A Correlation with Histological Study.

Authors:  Fernando Cobo; Angel Concha; Marta Ortiz
Journal:  Open Virol J       Date:  2009-09-04

10.  Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities.

Authors:  Angelo Meloni; Roberta Pilia; Marcello Campagna; Antonella Usai; Giuseppina Masia; Valeria Caredda; Rosa Cristina Coppola
Journal:  J Public Health Res       Date:  2014-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.